Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine

Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine

US Patent 12473251 · Granted Nov 18, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gingerenone A prodrugs as sensotherapeutics and methods of use2025
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-amin2024
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-amin2024
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 62023
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 62023
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 62023
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 62023
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 62023
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 62023
Substituted Imidazo[1,2-a]-pyridines as IRAK 1/4 and FLT3 inhibitors2023
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-amin2022
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-amin2022